alpha-aminopyridine has been researched along with Lymph Node Metastasis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyle, F; Campone, M; Cicin, I; Cortés, J; Cox, J; Frenzel, M; Guarneri, V; Hamilton, E; Harbeck, N; Headley, D; Hegg, R; Hulstijn, M; Huober, J; Johnston, SRD; Martin, M; Martinez Rodriguez, JL; Neven, P; O'Shaughnessy, J; Okada, M; Rastogi, P; San Antonio, B; Shao, ZM; Smith, IC; Sohn, J; Toi, M; Tolaney, SM; Wardley, A; Wei, R; Zhang, QY | 1 |
| Arteaga, CL; Blackwell, KL; Burris, HA; Cameron, DA; Campone, M; Conte, P; Elmeliegy, M; Germa, C; Hortobagyi, GN; Janni, W; Miller, M; Mondal, S; O'Shaughnessy, J; Paluch-Shimon, S; Petrakova, K; Sonke, GS; Stemmer, SM; Su, F; Verma, S; Winer, EP; Yap, YS | 1 |
| Ando, Y; Doi, T; Inada-Inoue, M; Kakizume, T; Mitsuma, A; Ohtsu, A; Quadt, C; Robson, M; Sato, M; Suenaga, N; Yoshino, T | 1 |
| Bu, G; Cao, L; Hu, X; Huang, C; Li, H; Li, P; Lin, G; Lin, H; Luo, M; Wu, S; Xie, J; Xu, H; Yang, X; Yang, Y; Yu, Q; Zhang, J; Zhang, YW; Zhao, X; Zheng, C; Zhou, J | 1 |
3 trial(s) available for alpha-aminopyridine and Lymph Node Metastasis
| Article | Year |
|---|---|
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Young Adult | 2020 |
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Double-Blind Method; Female; Follow-Up Studies; Humans; Letrozole; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Prognosis; Purines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate | 2018 |
Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors.
Topics: Adult; Aged; Aminopyridines; Antineoplastic Agents; Area Under Curve; Carcinoma, Squamous Cell; Colorectal Neoplasms; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Japan; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Treatment Outcome; Young Adult | 2014 |
1 other study(ies) available for alpha-aminopyridine and Lymph Node Metastasis
| Article | Year |
|---|---|
Cyclin-dependent kinase 5 decreases in gastric cancer and its nuclear accumulation suppresses gastric tumorigenesis.
Topics: Aminopyridines; Animals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase 5; Exportin 1 Protein; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Humans; Karyopherins; Lymphatic Metastasis; Male; Maleimides; Mice; Mice, Inbred BALB C; Prognosis; Protein Binding; Protein Structure, Tertiary; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Stomach; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2015 |